Cuba's bet on home-grown COVID vaccines is paying off
Abstract
Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials.
- Publication:
-
Nature
- Pub Date:
- November 2021
- DOI:
- 10.1038/d41586-021-03470-x
- Bibcode:
- 2021Natur.600...15R